A new dye to help surgeons see ovarian cancer during surgery
Instantaneous Tumor Spray for Real-Time Surgical Guidance
This study is testing a special dye that helps surgeons see hard-to-detect ovarian cancer tumors during surgery, making it easier for them to remove all the cancer and improve your chances of staying cancer-free.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Molecular Targeting Technologies, INC. NIH-funded |
| Lab location | 1 site (West Chester, United States) |
| Project ID | NIH-10681383 on NIH RePORTER |
What this research studies
This research focuses on developing a specialized dye that can be used during surgery to highlight ovarian cancer tumors that are otherwise difficult to see. The dye is designed to work with near-infrared fluorescence imaging, allowing surgeons to differentiate between healthy and cancerous tissue in real-time. By improving the visibility of small tumors, the goal is to enhance surgical outcomes and reduce the chances of cancer recurrence. This innovative approach aims to provide surgeons with better tools to make informed decisions during operations.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with early-stage ovarian cancer who are scheduled for surgical intervention.
Not a fit: Patients with advanced-stage ovarian cancer who are not candidates for surgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved surgical outcomes and longer disease-free periods for ovarian cancer patients.
How similar studies have performed: Other studies have shown promise in using fluorescence imaging techniques for tumor visualization, indicating that this approach may be effective.
Where this research is happening
West Chester, United States
- Molecular Targeting Technologies, INC. — West Chester, United States (Active)
Researchers
- Principal investigator: Gray, Brian David — Molecular Targeting Technologies, INC.
- Study coordinator: Gray, Brian David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.